Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/29/2025

Lichen Sclerosus Clinical Presentation and Diagnosis

Clinical Features

  • Lichen sclerosus is a chronic inflammatory dermatosis that causes loss of labial architecture through scarring, fusion of the labia minora, and can lead to fissures and ulcerations, affecting the anogenital area in 85-98% of female patients 1, 2, 4, 5
  • The disease presents with porcelain-white papules and plaques affecting the interlabial sulci, labia minora, clitoral hood, clitoris, perineal body and perineum 2, 3
  • Fragile, thinned and atrophic skin with a characteristic figure-eight pattern around the vulva and anus is a common feature 1, 4, 5
  • Fissures and tears develop with time, leading to pain and potential ulceration 1, 4
  • Scarring causes fusion of the labia minora and narrowing of the introitus 1, 4, 5
  • Areas of ecchymosis often accompany the white plaques 2, 3

Diagnostic Features

  • The loss of labial distinction occurs through progressive scarring, with fusion of the labia minora eliminating the normal anatomical boundaries between structures 1, 4
  • Buried clitoris results from sealing of the clitoral hood 1, 2, 3

Epidemiology

  • Lichen sclerosus has a bimodal age distribution with peaks in prepubertal girls and postmenopausal women 2, 3
  • The disease is more prevalent in women than men with ratios of 6:1 to 10:1 4, 5
  • Most commonly presents in postmenopausal women in the fifth to sixth decade of life 4, 5

Symptoms

  • Intractable pruritus is the main symptom, often worse at night 1, 2, 3, 4
  • Dyspareunia occurs with erosions, fissures, or introital narrowing 1, 2, 3
  • Dysuria and pain on defecation from perianal involvement 1, 4
  • Some patients remain asymptomatic despite visible disease 2, 3

Etiology

  • Lichen sclerosus is considered an autoimmune inflammatory dermatosis with evidence including increased incidence of tissue-specific antibodies, associations with other autoimmune diseases, and positive associations with HLA class II antigens 2, 3